Vitamin C COVID

So why are hospitals being prohibited from using it?

It's is an antioxidant, an anti-viral, and an anti-inflammatory with no reported adverse events in published clinical trials. So why not give it to COVID patients?

In Sayer's latest interview, he dives deep with one of the world's foremost experts on vitamin C therapy, juxtaposing the extreme controversy and hype around ivermectin with this far more suppressed, effective, safe, affordable and available therapy that virtually no one is talking about despite its clinically validated role, and over 80 years of research proving its relevance to our times!

Micronutrients for Viral Infections Journal of Orthomolecular Medicine 50th Annual International Conference

This article may be...

The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented challenges to the healthcare systems in almost every country around the world. Currently, there ...

Ascorbyl Palmitate (Vitamin C Ester) by BulkSupplements. What Is Ascorbyl Palmitate? Benefits, dosage, and customer reviews. Antioxidant supplement.

A medical team from the Second Affiliated Hospital of Xi'an Jiaotong University in China has reported the successful treatment of coronavirus patients with vitamin C

This article may be...

Coronavirus disease-19 (COVID-19) has been regarded as an infective-inflammatory disease, which affects mainly lungs. More recently, a multi-organ involvement has been highlighted, with different pathways of injury. A hemoglobinopathy, hypoxia and cell ...

This article may be...

This article may be...

This article may be...

This article may be...

On January 27, 2020 we published a press release from Orthomolecular Medicine News Service regarding Vitamin C and its use in treating the Coronavirus. It soon went viral on Facebook, until Facebook labeled it as "Fake News." Facebook partners with a website called "Lead Stories" to discredit news stories they do not want becoming popular on Facebook. Health Impact News is a popular target of "Lead Stories." Since we published this news release in January, however, several hospitals in China have begun to conduct trials on intravenous Vitamin C therapy, so it is hardly "Fake News" as Facebook is claiming. In fact, Facebook is the one guilty of promoting "Fake News" by erroneously claiming there is no proof that Vitamin C can help combat the Coronavirus, when in fact clinical research trials are well underway in China with ample evidence that should be shared with the public, and not suppressed, simply because U.S. sources in bed with Big Pharma do not want the public to have this information. Orthomolecular Medicine News Service editor Andrew Saul has just published an updated report, and he notes: "The World Health Organization (WHO) has, literally, met with Google and Facebook and other media giants to stop the spread of what they declare to be wrong information. Physician-directed, hospital-based administration of intravenous vitamin C has been marginalized or discredited. Scientific debate over COVID-19 appears to not be allowed. Ironically, Facebook, blocking any significant users' sharing of the news of approved vitamin therapy research, is itself blocked in China by the Chinese government. As for the internet, yes, China has it. And yes, it is censored. But, significantly, the Chinese government has not blocked this real news on how intravenous vitamin C will save lives in the COVID-19 epidemic." Hence, the news about Vitamin C therapy helping with the Coronavirus outbreak is found mostly in Chinese language websites, endorsed by the Communist China Government's controlled media, but mostly banned in the English language social media platforms like Facebook, or censored from Google search results.

This article may be...

There are limited proven therapies for COVID-19. Vitamin C’s antioxidant, anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical care of COVID-19. This literature review focuses on vitamin C deficiency in respiratory infections, including COVID-19, and the mechanisms of action in infectious disease, including support of the stress response, its role in preventing and treating colds and pneumonia, and its role in treating sepsis and COVID-19. The evidence to date indicates that oral vitamin C (2–8 g/day) may reduce the incidence and duration of respiratory infections and intravenous vitamin C (6–24 g/day) has been shown to reduce mortality, intensive care unit (ICU) and hospital stays, and time on mechanical ventilation for severe respiratory infections. Further trials are urgently warranted. Given the favourable safety profile and low cost of vitamin C, and the frequency of vitamin C deficiency in respiratory infections, it may be worthwhile testing patients’ vitamin C status and treating them accordingly with intravenous administration within ICUs and oral administration in hospitalised persons with COVID-19.

With the rapid, global spread of severe acute respiratory syndrome coronavirus 2, hospitals have become inundated with patients suffering from coronavirus disease 2019. Consultation-liaison psychiatrists are actively involved in managing these patients ...

This article may be...

This article may be...